MALDI imaging mass spectrometry differentiates basal cell carcinoma from trichoblastoma and trichoepithelioma: A proof of principle study

Authors

  • Jennifer M. C. Ranes Author
  • Jessica L. Moore Author
  • Nathan H. Patterson Author
  • Sarah P. Nicholson Author
  • Sara Kantrow Author
  • Jason Robbins Author
  • Richard M. Caprioloi Author
  • Jeremy L. Norris Author
  • Rami N. Al-Rohil Author

Keywords:

Clinical Medicine & Pharmacology

Abstract

Background: Basal cell carcinoma (BCC) comprises a large portion of dermatopathology specimens; however, benign mimics such as trichoblastoma/trichoepithelioma (TB/TE) place accurate diagnosis at risk and consequently lead to inappropriate clinical management and overuse of healthcare resources. This study aims to address the challenges of traditional histopathological evaluation by utilizing matrix-assisted laser desorption ionization imaging mass spectrometry (MALDI IMS). Methods and Findings: Formalin-fixed paraffin-embedded BCC and TB/TE tissue blocks were taken from archival tissue. A cohort of 69 BCC and TB/TE specimens were identified, each having three concordant diagnoses given by Dermatopathologists after a blinded analysis. H&E stained sections of each specimen were imaged for pathological analysis and uploaded to a digital annotation software with the following classifications: BCC, TB, TE, BCC stroma, TB stroma, and TE stroma. Mass spectra were collected from unstained serial sections guided by the areas annotated by the Dermatopathologists on the H&E stained serial sections. Before informatics, the data from the cohort were divided randomly into a training set (n = 55) and a validation set (n = 14). Prediction models were developed using a support vector machine (SVM) classification model from the training set data. Conclusions: Our study proves that BCC and TB/TE exhibit different proteomic profiles that one can use to enable accurate differential diagnosis. While our findings are not yet validated for clinical use, this merits further research to support IMS as an ancillary diagnostic tool for adequately and efficiently identifying the most common cutaneous malignancy in the United States. We recommend that future studies obtain a more extensive set of histologically challenging cases from multiple institutions and adequate clinical follow-up to confirm diagnostic accuracy.

Publication information

Originally published in PLOS ONE on 2025-05-12. Original DOI: 10.1371/journal.pone.0323475.

The original full text is available here under CC0 1.0. The displayed publication date is the original publication date.

Downloads

Original publication date

2025-05-12

Issue

Section

Research Articles